Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Alzheimer's disease and mild cognitive impairment deteriorate fine movement control.
Yan JH, Rountree S, Massman P, Doody RS, Li H. Yan JH, et al. J Psychiatr Res. 2008 Oct;42(14):1203-12. doi: 10.1016/j.jpsychires.2008.01.006. Epub 2008 Feb 15. J Psychiatr Res. 2008. PMID: 18280503 Clinical Trial.
Sensory-motor dysfunctions are often associated with Alzheimer's disease (AD) or mild cognitive impairment (MCI). This study suggests that deterioration in fine motor control and coordination characterizes sensory-mot …
Sensory-motor dysfunctions are often associated with Alzheimer's disease (AD) or mild cognitive impair
Characterization of the fine motor problems in patients with cognitive dysfunction - A computerized handwriting analysis.
Yu NY, Chang SH. Yu NY, et al. Hum Mov Sci. 2019 Jun;65:S0167-9457(17)30841-2. doi: 10.1016/j.humov.2018.06.006. Epub 2018 Jun 20. Hum Mov Sci. 2019. PMID: 29934222
This study recruited 22 participants with Alzheimer's disease (AD) and 14 with amnestic mild cognitive impairment (aMCI); 18 age- and gender-matched healthy elderly individuals made up the health control. ...The results in geograph …
This study recruited 22 participants with Alzheimer's disease (AD) and 14 with amnestic mild cognitive
Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease.
Muhlack S, Przuntek H, Müller T. Muhlack S, et al. Pharmacopsychiatry. 2006 Jan;39(1):16-9. doi: 10.1055/s-2006-931473. Pharmacopsychiatry. 2006. PMID: 16453249 Clinical Trial.
BACKGROUND: There is a debate about the deterioration of fine motor behavior during treatment with cholinesterase inhibitors. METHODS: We used an instrumental motor test, which demands a complex motion series. Thereby we assessed motor function in patients with A
BACKGROUND: There is a debate about the deterioration of fine motor behavior during treatment with cholinesterase inhibitors. …
Feedback